Stockreport

Alnylam Pharmaceuticals: Q3 Earnings Review - A Sensational Year Reaches Its Peak [Seeking Alpha]

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview
PDF ALNY's market cap surged to $59B as Amvuttra outperformed rivals, but valuation appears stretched at a forward P/S ratio of ~16x. The pipeline is robust, with promisi [Read more]